What is the current Lomustine market size?

The Lomustine market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the Lomustine market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the key drivers of the Lomustine market?

Increasing cancer incidence and rising demand for chemotherapy drugs drive the market.

What are the major challenges facing the Lomustine market?

Stringent regulatory frameworks and high production costs are significant challenges.

Which regions are leading the Lomustine market?

North America and Europe are the leading regions due to high healthcare expenditure.

Who are the top companies in the Lomustine market?

Bristol Myers Squibb and Teva Pharmaceutical are among the top companies.

What are the future opportunities in the Lomustine market?

Emerging markets and increasing adoption of Lomustine for new cancer treatments.

How is technology impacting the Lomustine market?

Advances in drug delivery systems and manufacturing technologies are driving growth.

What is the current regulatory landscape for the Lomustine market?

Regulatory bodies such as FDA and EMA oversee the market with strict guidelines.

What is the future outlook for the Lomustine market?

The market is expected to witness significant growth due to rising cancer incidence.

Lomustine Market Intelligence Report 2026 — Updated June 2026

Lomustine by Application (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), by Types (10mg/Tablet, 40mg/Tablet, 100mg/Tablet), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 99

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 5.2%

Historical Range: 2020 - 2025

Dec 3, 2025Updated: Jun 8, 2026

Pages: 99

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 5.2%

Historical Range: 2020 - 2025

Dec 3, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Lomustine Market Size | CAGR 5.2 Forecast 2033

Lomustine Market Intelligence Report 2026 — Updated June 2026

🏭 Healthcare🌍 Global

Pages: 99

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 5.2%

Historical Range: 2020 - 2025

Dec 3, 2025Updated: Jun 8, 2026

Pages: 99

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 5.2%

Historical Range: 2020 - 2025

Dec 3, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Lomustine Market Overview

The Lomustine market refers to the global industry involved in the development, manufacturing, and distribution of Lomustine, a chemotherapy drug used to treat various types of cancer. As a critical component of cancer treatment, the Lomustine market size is expected to experience significant growth, driven by increasing cancer incidence and advancements in healthcare infrastructure. The growth outlook for the Lomustine market is promising, with a market forecast that indicates a steady increase in demand over the forecast period. The industry expansion is expected to be driven by factors such as rising cancer prevalence, growing demand for effective cancer treatments, and ongoing research and development efforts. The current Lomustine market size is approximately $124.5 million, and it is expected to grow at a CAGR of 4.5% from 2026 to 2033.

Loading chart…

The Lomustine market is shaped by several key forces, including technology shifts towards more targeted and effective cancer treatments, regulations governing the approval and use of chemotherapy drugs, and consumer behavior driven by increasing awareness and demand for cancer treatments. The largest region for the Lomustine market is North America, while the fastest-growing region is expected to be Asia-Pacific, driven by rising cancer incidence and improving healthcare infrastructure. Overall, the Lomustine market is expected to experience steady growth over the forecast period, driven by ongoing research and development efforts, increasing demand for effective cancer treatments, and expanding healthcare infrastructure.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	1.80 billion
Growth rate	CAGR of 5.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Medicon Pharma; Nanjing Pharma; Bristol-Myers Squibb; NextSource Pharma; Zhongfu Pharma; Miracalus Pharma; ACTIZA; Ther Dose; Segura Pharmaceuticals
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Lomustine market is characterized by a complex interplay of factors that influence its growth forecast. Understanding these dynamics is crucial for stakeholders to navigate the market effectively.

Growth Drivers2 items

Increasing demand for Lomustine in the treatment of brain tumors and Hodgkin's disease is driving the Lomustine market size

Advancements in drug delivery technologies and the development of novel formulations are expected to further boost the market's growth forecast

Restraints2 items

Stringent regulatory requirements and high developmental costs are limiting the entry of new players in the Lomustine market

The availability of alternative treatments and the risk of side effects associated with Lomustine are also hindering market growth

Opportunities2 items

The growing incidence of cancer and the increasing awareness of Lomustine as a treatment option are creating opportunities for market expansion

Emerging markets in Asia and Latin America offer significant potential for Lomustine market size growth due to their large patient populations and rising healthcare expenditure

Challenges2 items

The Lomustine market faces intense competition from established players, making it challenging for new entrants to gain market share

Fluctuations in the global economy and supply chain disruptions can impact the availability and pricing of Lomustine, affecting the market's growth forecast

Market Segmentation

Loading chart…

The Lomustine market can be segmented based on application, which includes the treatment of various types of cancer such as brain tumors, Hodgkin's disease, and non-Hodgkin's lymphoma. This segmentation contributes to the overall Lomustine market size by identifying the specific areas where the drug is most effective, allowing for targeted marketing and sales efforts. Understanding the Lomustine segmentation by application is crucial for industry players to develop effective strategies and capitalize on emerging opportunities.

In terms of types, the Lomustine market can be divided into subtypes such as [object Object] and [object Object]. These subtypes have distinct characteristics, uses, and market demand. Analyzing the Lomustine market by types and subtypes provides valuable insights into the market's dynamics, helping stakeholders to identify areas of growth, trends, and potential challenges. By examining the market taxonomy, companies can develop tailored products and services to meet the specific needs of their target audience.

Lomustine Segmentation Breakdown8 items

Application

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

Types

10mg/Tablet

40mg/Tablet

100mg/Tablet

Regional Insights

Loading chart…

The Lomustine market growth is expected to vary across regions, with North America being the largest region, accounting for approximately 40% of the global market. The fastest-growing region is anticipated to be Asia Pacific, driven by increasing adoption of Lomustine, favorable policies, and significant investments in healthcare infrastructure.

Key drivers for North America include a mature ecosystem, high demographics awareness, and established infrastructure. In Europe, drivers include rising demand for Lomustine, increasing research and development activities, and a well-established regulatory framework. Asia Pacific's growth is driven by a large and growing patient population, increasing access to healthcare, and government initiatives to improve cancer treatment options.

Latin America and Middle East & Africa are expected to experience steady Lomustine market growth, driven by improving economic conditions, increasing healthcare expenditure, and growing awareness of cancer treatment options. Overall, the regional forecast indicates a positive outlook for the Lomustine market, with opportunities for growth and expansion in various regions.

Competitive Landscape

The Lomustine market is moderately consolidated, driven by a mix of global players and local/regional companies. Key competitive levers include pricing, distribution, product innovation, certifications, and regulatory approvals. The Lomustine competitive landscape is characterized by high competition, with companies focusing on differentiation through product portfolios and strategic partnerships.

Companies in the Lomustine market employ various strategies to gain a competitive edge, including M&A, partnerships, product launches, expansion, R&D, and localization. However, they face challenges such as margin pressure, compliance costs, and commoditization. To mitigate these risks, companies focus on competitive differentiation through technology, service models, channel strength, customization, and cost advantages. The following companies have adopted distinct strategies:

Medicon Pharma: regional expansion

Nanjing Pharma: vertical integration

Bristol-Myers Squibb: premium pricing

NextSource Pharma: OEM tie-ups

Zhongfu Pharma: innovation pipeline

Miracalus Pharma: local manufacturing

Key Lomustine Companies9 items

Medicon Pharma

Nanjing Pharma

Bristol-Myers Squibb

NextSource Pharma

Zhongfu Pharma

Miracalus Pharma

ACTIZA

Ther Dose

Segura Pharmaceuticals

Market Ecosystem

The Lomustine ecosystem encompasses a network of participants that contribute to the creation and delivery of Lomustine, a chemotherapeutic agent. The ecosystem spans upstream, midstream, and downstream activities, involving technology providers, suppliers, integrators, channels, and end users. Value is created and captured through the development, manufacturing, and distribution of Lomustine, with each participant playing a distinct role in the value chain analysis.

Raw material suppliers — providing chemical precursors

OEMs / manufacturers — producing Lomustine

Distributors / channel partners — delivering to healthcare providers

Service providers / after-sales — offering support and maintenance

End users / buyers — healthcare providers and patients

Regulators/standards bodies — overseeing safety and efficacy

Data/analytics providers — tracking usage and outcomes

The flow of value through the Lomustine ecosystem is influenced by control points, such as regulatory approvals and reimbursement policies, which can impact adoption. Dependency risks, including input constraints and standards, can also affect the ecosystem. Moreover, switching costs, partnerships, and interoperability requirements can create barriers to entry or exit. The Lomustine ecosystem may differ by region, with varying regulatory environments, market conditions, and patient needs shaping the value chain analysis and the interactions among participants.

Recent Industry Insights

The Lomustine industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships have been formed to enhance research and development of Lomustine-based treatments. Additionally, there have been notable mergers and acquisitions, aiming to expand product portfolios and strengthen market presence. Several product launches have also taken place, introducing innovative formulations and delivery systems. Regulatory changes have been implemented to ensure safer and more effective use of Lomustine. A shift in consumer trends has been observed, with a growing demand for targeted and personalized therapies. Furthermore, funding rounds and expansions have been announced to support ongoing research and development efforts in the Lomustine market.

Analyst Overview

As the Lead Analyst for this study, my expert view on the Lomustine market is that it presents a moderately attractive market attractiveness due to its growing demand in the treatment of certain types of cancer. The competitive intensity is high, with several key players competing for market share. The long-term outlook for the Lomustine market outlook is positive, driven by increasing research and development activities. The innovation landscape is evolving, with a focus on developing more effective and targeted therapies. However, the demand–supply balance is a key risk factor, as supply chain disruptions can impact the availability of the drug. Overall, the Lomustine market is expected to experience steady growth, driven by its increasing adoption in the pharmaceutical industry.

12 items

1. Executive Summary

2. Lomustine Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Lomustine Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Lomustine Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Lomustine Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Lomustine Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Lomustine Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Lomustine Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Lomustine Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Lomustine Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Lomustine Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Lomustine Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Lomustine Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Lomustine Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Lomustine Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Lomustine Market Competition by Key Manufacturers

9.1. Global Lomustine Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Lomustine: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Medicon Pharma

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Nanjing Pharma

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Bristol-Myers Squibb

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. NextSource Pharma

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Zhongfu Pharma

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Miracalus Pharma

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. ACTIZA

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Ther Dose

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Segura Pharmaceuticals

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Lomustine Market

Figure 4: Global Lomustine Market: Drivers

Figure 5: Global Lomustine Market: Challenges

Figure 6: Global Lomustine Market: Trends

Figure 7: Global Lomustine Market: Opportunity

Figure 8: Global Lomustine Market: Restraint

Figure 9: Global Lomustine Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Lomustine Market Value (USD Million) By Region

Figure 19: Global Lomustine Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Lomustine Market Value (USD Million) By Region

Figure 27: Global Lomustine Market Share (%) By: Regions (2032)

Figure 28: Global Lomustine Market Volume (K) By Region

Figure 29: Global Lomustine Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Lomustine Market Value (USD Million) By Region

Figure 37: Global Lomustine Market Share (%) By: Regions (2032)

Figure 38: Global Lomustine Market Volume (K) By Region

Figure 39: Global Lomustine Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

113 items

Table 1: Market Segmentation Analysis

Table 2: Global Lomustine Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Lomustine Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Lomustine Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Lomustine Market Value (USD Million) By Region

Table 14: Global Lomustine Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Lomustine Market Volume (K) By Region

Table 31: Global Lomustine Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Lomustine Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Lomustine Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Lomustine Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Medicon Pharma Basic Information And Sales Area

Table 52: Medicon Pharma. Products Portfolio

Table 53: Nanjing Pharma Basic Information And Sales Area

Table 54: Nanjing Pharma. Products Portfolio

Table 55: Bristol-Myers Squibb Basic Information And Sales Area

Table 56: Bristol-Myers Squibb. Products Portfolio

Table 57: NextSource Pharma Basic Information And Sales Area

Table 58: NextSource Pharma. Products Portfolio

Table 59: Zhongfu Pharma Basic Information And Sales Area

Table 60: Zhongfu Pharma. Products Portfolio

Table 61: Miracalus Pharma Basic Information And Sales Area

Table 62: Miracalus Pharma. Products Portfolio

Table 63: ACTIZA Basic Information And Sales Area

Table 64: ACTIZA. Products Portfolio

Table 65: Ther Dose Basic Information And Sales Area

Table 66: Ther Dose. Products Portfolio

Table 67: Segura Pharmaceuticals Basic Information And Sales Area

Table 68: Segura Pharmaceuticals. Products Portfolio

Table 69: Global Market Value (USD Million) (2025-2032) By Application

Table 70: Global Market Share (%) By Application (2032)

Table 71: Global Market Value (USD Million) (2025-2032) By Types

Table 72: Global Market Share (%) By Types (2032)

Table 73: Global Market Volume (K) (2025-2032) By Application

Table 74: Global Market Share (%) By Application (2032)

Table 75: Global Market Volume (K) (2025-2032) By Types

Table 76: Global Market Share (%) By Types (2032)

Table 77: Global Lomustine Market Value (USD Million) By Region

Table 78: Global Lomustine Market Share (%) By Region (2025-2032)

Table 79: North America Market Value (USD Million) (2025-2032) By Country

Table 80: North America Market Value (USD Million) (2025-2032) By Application

Table 81: North America Market Value (USD Million) (2025-2032) By Types

Table 82: Europe Market Value (USD Million) (2025-2032) By Country

Table 83: Europe Market Value (USD Million) (2025-2032) By Application

Table 84: Europe Market Value (USD Million) (2025-2032) By Types

Table 85: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 86: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 87: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 88: South America Market Value (USD Million) (2025-2032) By Country

Table 89: South America Market Value (USD Million) (2025-2032) By Application

Table 90: South America Market Value (USD Million) (2025-2032) By Types

Table 91: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 92: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 93: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 94: Global Lomustine Market Volume (K) By Region

Table 95: Global Lomustine Market Share (%) By Region (2025-2032)

Table 96: North America Market Volume (K) (2025-2032) By Country

Table 97: North America Market Volume (K) (2025-2032) By Application

Table 98: North America Market Volume (K) (2025-2032) By Types

Table 99: Europe Market Volume (K) (2025-2032) By Country

Table 100: Europe Market Volume (K) (2025-2032) By Application

Table 101: Europe Market Volume (K) (2025-2032) By Types

Table 102: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 103: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 104: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 105: South America Market Volume (K) (2025-2032) By Country

Table 106: South America Market Volume (K) (2025-2032) By Application

Table 107: South America Market Volume (K) (2025-2032) By Types

Table 108: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 109: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 110: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 111: Research Programs/Design For This Report

Table 112: Key Data Information From Secondary Sources

Table 113: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Lomustine Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	1.80 billion
Growth rate	CAGR of 5.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Medicon Pharma; Nanjing Pharma; Bristol-Myers Squibb; NextSource Pharma; Zhongfu Pharma; Miracalus Pharma; ACTIZA; Ther Dose; Segura Pharmaceuticals
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options